Literature DB >> 22039052

Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site.

Naomi J Wangler1, Kira L Santos, Ines Schadock, Fred K Hagen, Emanuel Escher, Michael Bader, Robert C Speth, Vardan T Karamyan.   

Abstract

Recently, we discovered a novel non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site in rodent and human brain membranes, which is distinctly different from angiotensin receptors and key proteases processing angiotensins. It is hypothesized to be a new member of the renin-angiotensin system. This study was designed to isolate and identify this novel angiotensin binding site. An angiotensin analog, photoaffinity probe 125I-SBpa-Ang II, was used to specifically label the non-AT1, non-AT2 angiotensin binding site in mouse forebrain membranes, followed by a two-step purification procedure based on the molecular size and isoelectric point of the photoradiolabeled binding protein. Purified samples were subjected to two-dimensional gel electrophoresis followed by mass spectrometry identification of proteins in the two-dimensional gel sections containing radioactivity. LC-MS/MS analysis revealed eight protein candidates, of which the four most abundant were immunoprecipitated after photoradiolabeling. Immunoprecipitation studies indicated that the angiotensin binding site might be the membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16). To verify these observations, radioligand binding and photoradiolabeling experiments were conducted in membrane preparations of HEK293 cells overexpressing mouse neurolysin or thimet oligopeptidase (EC 3.4.24.15), a closely related metalloendopeptidase of the same family. These experiments also identified neurolysin as the non-AT1, non-AT2 angiotensin binding site. Finally, brain membranes of mice lacking neurolysin were nearly devoid of the non-AT1, non-AT2 angiotensin binding site, further establishing membrane-bound neurolysin as the binding site. Future studies will focus on the functional significance of this highly specific, high affinity interaction between neurolysin and angiotensins.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039052      PMCID: PMC3249063          DOI: 10.1074/jbc.M111.273052

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16.

Authors:  P Dahms; R Mentlein
Journal:  Eur J Biochem       Date:  1992-08-15

2.  Molecular cloning and expression of rat brain endopeptidase 3.4.24.16.

Authors:  P Dauch; J P Vincent; F Checler
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

3.  Neurolysin: purification and assays.

Authors:  F Checler; H Barelli; P Dauch; V Dive; B Vincent; J P Vincent
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes.

Authors:  B Vincent; A Beaudet; P Dauch; J P Vincent; F Checler
Journal:  J Neurosci       Date:  1996-08-15       Impact factor: 6.167

5.  Purification and properties of a soluble angiotensin II-binding protein from rabbit liver.

Authors:  M A Kiron; R L Soffer
Journal:  J Biol Chem       Date:  1989-03-05       Impact factor: 5.157

6.  Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells.

Authors:  Héctor A Lucero; Ekaterina Kintsurashvili; Maria E Marketou; Haralambos Gavras
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

7.  Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15.

Authors:  V Rioli; A Kato; F C Portaro; G K Cury; K te Kaat; B Vincent; F Checler; A C Camargo; M J Glucksman; J L Roberts; S Hirose; E S Ferro
Journal:  Biochem Biophys Res Commun       Date:  1998-09-08       Impact factor: 3.575

8.  Endopeptidase 24.16B. A new variant of endopeptidase 24.16.

Authors:  D Rodd; L B Hersh
Journal:  J Biol Chem       Date:  1995-04-28       Impact factor: 5.157

9.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19

Review 10.  Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges.

Authors:  Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2007-03-30
View more
  17 in total

Review 1.  Intracardiac intracellular angiotensin system in diabetes.

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas; Kenneth M Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  The intracrine renin-angiotensin system.

Authors:  Rajesh Kumar; Candice M Thomas; Qian Chen Yong; Wen Chen; Kenneth M Baker
Journal:  Clin Sci (Lond)       Date:  2012-09       Impact factor: 6.124

3.  Peptidase neurolysin is an endogenous cerebroprotective mechanism in acute neurodegenerative disorders.

Authors:  Vardan T Karamyan
Journal:  Med Hypotheses       Date:  2019-07-13       Impact factor: 1.538

4.  A Group of Weakly Bound to Neurons Extracellular Metallopeptidases (NEMPs).

Authors:  Ekaterina S Kropotova; Mark I Mosevitsky
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

5.  Peptidase neurolysin functions to preserve the brain after ischemic stroke in male mice.

Authors:  Srinidhi Jayaraman; Abdullah Al Shoyaib; Joanna Kocot; Heidi Villalba; Faisal F Alamri; Mamoon Rashid; Naomi J Wangler; Ekram A Chowdhury; Nadezhda German; Thiruma V Arumugam; Thomas J Abbruscato; Vardan T Karamyan
Journal:  J Neurochem       Date:  2019-10-22       Impact factor: 5.372

6.  Pharmacological characterization of a novel non-AT1, non-AT2 angiotensin binding site identified as neurolysin.

Authors:  Jamala D Swindle; Kira L Santos; Robert C Speth
Journal:  Endocrine       Date:  2013-02-15       Impact factor: 3.633

Review 7.  Neurolysin: From Initial Detection to Latest Advances.

Authors:  Frédéric Checler; Emer S Ferro
Journal:  Neurochem Res       Date:  2018-08-29       Impact factor: 3.996

Review 8.  Electroosmotic perfusion of tissue: sampling the extracellular space and quantitative assessment of membrane-bound enzyme activity in organotypic hippocampal slice cultures.

Authors:  Yangguang Ou; Juanfang Wu; Mats Sandberg; Stephen G Weber
Journal:  Anal Bioanal Chem       Date:  2014-08-29       Impact factor: 4.142

9.  The effects of para-chloromercuribenzoic acid and different oxidative and sulfhydryl agents on a novel, non-AT1, non-AT2 angiotensin binding site identified as neurolysin.

Authors:  Kira L Santos; Megan A Vento; John W Wright; Robert C Speth
Journal:  Regul Pept       Date:  2013-03-16

10.  Identification and Characterization of Two Structurally Related Dipeptides that Enhance Catalytic Efficiency of Neurolysin.

Authors:  Srinidhi Jayaraman; Joanna Kocot; Shiva Hadi Esfahani; Naomi J Wangler; Arzu Uyar; Yehia Mechref; Paul C Trippier; Thomas J Abbruscato; Alex Dickson; Hideki Aihara; David A Ostrov; Vardan T Karamyan
Journal:  J Pharmacol Exp Ther       Date:  2021-08-13       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.